How Are Synaptic Vesicle Exocytosis and Endocytosis Affected in Parkinson Disease? Research Neurology Feb. 18, 2026
Rapid Eye Movement Sleep Behavior Disorder with Clinical Dementia with Lewy Bodies Phenotype but Lacking Postmortem Central Nervous System Synuclein Pathology: Alternate Etiologies. Research Movement disorders : official journal of the Movement Disorder Society Feb. 18, 2026
Altered phenotype and gene expression of regulatory T cells (Tregs) in children with Autism, and the relationship with comorbid gastrointestinal symptoms. Research Journal of neuroinflammation Feb. 17, 2026
Public involvement in the design of a complex neurosurgical clinical trial (the GDNF trial) and an associated support package: reflections and recommendations. Research Trials Feb. 17, 2026
[Impact of a community-based multisectoral intervention on the health of individuals with parkinson's disease and their family caregivers]. Research Semergen Feb. 17, 2026
The host-guest inclusion complex of Anle 138b with Methyl-β-cyclodextrin: In vitro characterization and possible formulation development for anti-Parkinson application. Research International journal of pharmaceutics Feb. 16, 2026
The promise of GLP-1 receptor agonists for neurodegenerative diseases. Research The Journal of clinical investigation Feb. 16, 2026
Investigating the Genetic Relationship Between Vitamin B12 Metabolism and Parkinson Disease. Research Neurology. Genetics Feb. 16, 2026
Natural Polyphenols Versus Standard Therapy: Effects on Neuroinflammation and Alpha-Synuclein Expression in a 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Induced Mouse Model of Parkinson's Disease. Research Cureus Feb. 15, 2026
Environmental Substances Associated with Neurodegeneration: An Overview of Parkinson's Disease and Related Genotoxic Endpoints. Research Genes Feb. 13, 2026
Remifentanil-esketamine-based General Anesthesia Strategy for Microelectrode-guided Deep-brain Stimulation for Parkinson Disease. Research Anesthesiology Feb. 13, 2026
DBS-related infections in Parkinson's disease: Incidence, risk factors, management and outcome. Research Revue neurologique Feb. 13, 2026
Towards biomarker-based diagnosis of Parkinson disease. Research Nature reviews. Neurology Feb. 13, 2026
Baseline Regional Cholinergic Denervation Predicts Cognitive Trajectories in Moderate Parkinson Disease. Research Annals of clinical and translational neurology Feb. 12, 2026
Generation of induced pluripotent stem cells (NIMHi027-A) from a Parkinson's disease patient harbouring a homozygous missense mutation for PLA2G6 gene (chr22:g.38112558CÂ >Â T). Research Stem cell research Feb. 12, 2026
Mitophagy bridges glucose metabolism, inflammation and neuroprotection in astrocytes. Research Autophagy Feb. 12, 2026
MSN Templated with L-Dopa Amide Derivatives Outperforms the Efficiency of Free-L-Dopa in Reducing Parkinson's Behavioral Dysfunction in Mice. Research International journal of nanomedicine Feb. 12, 2026
Moral decision-making in patients with neurodegenerative diseases: a systematic review. Research Frontiers in psychology Feb. 12, 2026
Miquelianin and spiraeoside from Filipendula ulmaria mitigate α-synuclein accumulation in C.elegans and reduce the expression of neuroinflammatory cytokines in human microglia. Research Frontiers in pharmacology Feb. 11, 2026
Differential Neural Substrates of Freezing of Gait in Cerebral Small Vessel Disease and Parkinson Disease: A Dual-tracer PET Study. Research Clinical nuclear medicine Feb. 11, 2026